Cells have a number of systems available to regulate intracellular ROS production and maintain redox homeostasis including the Trx system [33], which has been shown to be associated with clinical outcome in radiotherapy treated early stage breast cancer [50]. The gene discussed is TXN; the disease is breast carcinoma.